Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;11(6):1407-12.
doi: 10.1016/j.meegid.2011.05.005. Epub 2011 May 14.

Transmission probabilities and durations of immunity for three pathogenic group B Streptococcus serotypes

Affiliations

Transmission probabilities and durations of immunity for three pathogenic group B Streptococcus serotypes

Bethany Percha et al. Infect Genet Evol. 2011 Aug.

Abstract

Group B Streptococcus (GBS) remains a major cause of neonatal sepsis and is an emerging cause of invasive bacterial infections. The 9 known serotypes vary in virulence, and there is little cross-immunity. Key parameters for planning an effective vaccination strategy, such as average length of immunity and transmission probabilities by serotype, are unknown. We simulated GBS spread in a population using a computational model with parameters derived from studies of GBS sexual transmission in a college dormitory. Here we provide estimates of the duration of immunity relative to the transmission probabilities for the 3 GBS serotypes most associated with invasive disease: Ia, III, and V. We also place upper limits on the durations of immunity for serotype Ia (570 days), III (1125 days) and V (260 days). Better transmission estimates are required to establish the epidemiological parameters of GBS infection and determine the best vaccination strategies to prevent GBS disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distributions of relationship lengths, gap lengths, and rates of sexual contacts for male and female college freshmen (n = 299) in the study of Foxman et al. [20].
Figure 2
Figure 2
Probability per sex act that a susceptible individual will become infected, for females (βf) and males (βm), for various values of 1/δ, the average duration of immunity. The individual panels show (a) the general case (no serotype specificity), (b) serotype Ia, (c) serotype III, and (d) serotype V. Open circles represent the values of βf and filled circles the values of βm. Error bars are standard deviations on the sample mean for twenty repetitions of the calculation.

References

    1. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299:2056–2065. - PubMed
    1. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15–20. - PubMed
    1. Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4:932–942. - PMC - PubMed
    1. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988;319:1180–1185. - PubMed
    1. Paoletti LC, Wessels MR, Michon F, DiFabio J, Jennings HJ, Kasper DL. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1992;60:4009–4014. - PMC - PubMed

MeSH terms

Substances